- Home
- PCF vs SOPH Comparison
PCF vs SOPH Comparison
Compare PCF & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCF
- SOPH
- Stock Information
- Founded
- PCF 1987
- SOPH 2011
- Country
- PCF United States
- SOPH Switzerland
- Employees
- PCF N/A
- SOPH N/A
- Industry
- PCF Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCF Finance
- SOPH Health Care
- Exchange
- PCF Nasdaq
- SOPH Nasdaq
- Market Cap
- PCF 196.9M
- SOPH 206.6M
- IPO Year
- PCF N/A
- SOPH 2021
- Fundamental
- Price
- PCF $6.28
- SOPH $2.99
- Analyst Decision
- PCF
- SOPH Strong Buy
- Analyst Count
- PCF 0
- SOPH 2
- Target Price
- PCF N/A
- SOPH $6.50
- AVG Volume (30 Days)
- PCF 74.8K
- SOPH 26.8K
- Earning Date
- PCF 01-01-0001
- SOPH 05-06-2025
- Dividend Yield
- PCF 10.90%
- SOPH N/A
- EPS Growth
- PCF N/A
- SOPH N/A
- EPS
- PCF N/A
- SOPH N/A
- Revenue
- PCF N/A
- SOPH $67,173,000.00
- Revenue This Year
- PCF N/A
- SOPH $14.86
- Revenue Next Year
- PCF N/A
- SOPH $22.76
- P/E Ratio
- PCF N/A
- SOPH N/A
- Revenue Growth
- PCF N/A
- SOPH 4.66
- 52 Week Low
- PCF $5.71
- SOPH $2.58
- 52 Week High
- PCF $6.96
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- PCF 50.54
- SOPH 47.34
- Support Level
- PCF $6.20
- SOPH $2.90
- Resistance Level
- PCF $6.33
- SOPH $3.33
- Average True Range (ATR)
- PCF 0.09
- SOPH 0.21
- MACD
- PCF 0.04
- SOPH 0.01
- Stochastic Oscillator
- PCF 79.79
- SOPH 44.46
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.